Tumber A, Morgan H M, Meikle M C, Hill P A
Bone Biology Unit, Department of Orthodontics and Paediatric Dentistry, Guy's, King's and St. Thomas' School of Medicine and Dentistry, Guy's Hospital, London, United Kingdom.
Int J Cancer. 2001 Mar 1;91(5):665-72. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1101>3.0.co;2-0.
A central event in bone resorption is the recruitment of osteoclasts to future resorption sites. Breast-cancer cells invariably metastasise to the skeleton and induce extensive bone destruction by osteoclasts. However, our understanding of the mechanisms by which cancer cells interact with osteoclasts remains unclear. Consequently, we compared the effects of conditioned medium (CM) from 2 human breast-cancer cell lines, MB-MDA-231 and MCF-7, with those of a normal human breast epithelial cell line, HME, on osteoclastic fusion, resorptive activity and migration from the periosteum to the developing marrow cavity of fetal mouse metatarsals in culture. Osteoclastic resorptive activity was assessed by pre-labelling 17-day-old fetal metatarsal explants with 45Ca, whilst fusion and migration were monitored by histomorphometry and osteoclasts were identified by their tartrate-resistant acid phosphatase activity. CM from TPA-stimulated breast-cancer cell lines produced a significant increase in osteoclastic resorptive activity, whilst the normal breast cell line produced a minimal increase. The breast-cancer cell lines also stimulated osteoclastic fusion and migration in the metatarsal explants, but the normal breast cell line was without effect. The stimulatory effect of CM from MDA-MB-231 cells on osteoclastic fusion, but not migration, was partially inhibited by preventing prostaglandin and leukotriene synthesis by cells within the bone explants. In contrast, a synthetic matrix metalloproteinase (MMP) inhibitor, but not a cysteine proteinase inhibitor, prevented the migration of osteoclasts to the calcified centre of the metatarsal explants in response to CM from MDA-MB-231 cells. MDA-MB-231 cells also induced an increase in the expression of MMP-9 by migrating osteoclasts. Fractionation of the TPA-stimulated breast cancer cell CM established that the resorptive activity was associated with factors of m.w. >3 kDa. We determined by immuno-assay that human breast-cancer cells secrete parathyroid hormone-related protein (PTH-rP), tumour necrosis factor-alpha (TNF-alpha) and interleukins (ILs) 6 and 11. Neutralizing experiments with human antibodies to these cytokines established that PTH-rP and TNF-alpha production by MDA-MB-231 cells were responsible for mediating their effects on osteoclastic migration and ultimately bone resorption in the metatarsal explants.
骨吸收过程中的一个核心事件是破骨细胞被招募至未来的吸收位点。乳腺癌细胞总是会转移至骨骼,并通过破骨细胞诱导广泛的骨质破坏。然而,我们对于癌细胞与破骨细胞相互作用机制的理解仍不清楚。因此,我们比较了来自两种人乳腺癌细胞系(MB-MDA-231和MCF-7)的条件培养基(CM)与正常人乳腺上皮细胞系(HME)的条件培养基对破骨细胞融合、吸收活性以及在培养的胎鼠跖骨中从骨膜迁移至发育中的骨髓腔的影响。通过用45Ca预标记17日龄的胎鼠跖骨外植体来评估破骨细胞的吸收活性,同时通过组织形态计量学监测融合和迁移情况,并根据抗酒石酸酸性磷酸酶活性鉴定破骨细胞。来自经佛波酯(TPA)刺激的乳腺癌细胞系的条件培养基使破骨细胞吸收活性显著增加,而正常乳腺细胞系的条件培养基仅使其有极小的增加。乳腺癌细胞系还刺激了跖骨外植体中的破骨细胞融合和迁移,但正常乳腺细胞系则无此作用。通过阻止骨外植体中的细胞合成前列腺素和白三烯,可部分抑制MDA-MB-231细胞的条件培养基对破骨细胞融合(而非迁移)的刺激作用。相反,一种合成的基质金属蛋白酶(MMP)抑制剂而非半胱氨酸蛋白酶抑制剂,可阻止破骨细胞响应MDA-MB-231细胞的条件培养基向跖骨外植体的钙化中心迁移。MDA-MB-231细胞还可诱导迁移的破骨细胞中MMP-9表达增加。对经TPA刺激的乳腺癌细胞条件培养基进行分级分离表明,吸收活性与分子量>3 kDa的因子有关。我们通过免疫测定确定,人乳腺癌细胞分泌甲状旁腺激素相关蛋白(PTH-rP)、肿瘤坏死因子-α(TNF-α)以及白细胞介素(ILs)6和11。用针对这些细胞因子的人抗体进行的中和实验表明,MDA-MB-231细胞产生的PTH-rP和TNF-α介导了它们对破骨细胞迁移以及最终对跖骨外植体骨吸收的影响。